February 27, 2025 10:09 AM EST
News Briefing

Han­soh ends col­lab­o­ra­tion with Si­lence; Vir hunts for HBV drug part­ner

ENDPOINTS

Plus, news about Alopexx, Medi­gene, EpimAb and Be­lite Bio:

Han­soh backs out of siR­NA pact with Si­lence Ther­a­peu­tics: The Lon­don-based biotech

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Can Bill An­der­son save Bay­er?

Verve is lat­est gene edit­ing com­pa­ny to suf­fer set­back, as Ver­tex walks away from pact

Up­dat­ed: Lil­ly joins Trump ad­min­is­tra­tion to an­nounce $27B man­u­fac­tur­ing com­mit­ment

Drug pol­i­cy vet­er­an at CMS to de­part on Fri­day

FDA meet­ing to pick next win­ter's flu shot is can­celed, in omi­nous sign for US vac­cine pol­i­cy

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times